In fiscal 2024, which ended Dec 31, 2025, P3 Health Partners Inc. reported revenue of $1.5 billion, up 15.2% from the year before. It recorded a net loss of $147.9 million. The operating loss came to $270.3 million, an operating margin of -18.5%. Diluted earnings per share were -$45.26. Across the 5 fiscal years shown, revenue grew from $578.6 million in fiscal 2021 to $1.5 billion in fiscal 2024, about 26.0% a year.
USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.
| Line |
FY 2026
Jun 30, 2026
|
FY 2024
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 2, 2021
|
|---|---|---|---|---|---|---|
| Revenue |
—
|
1,459
+15.2%
|
1,500
+18.5%
|
1,266
+20.7%
|
1,049
+81.4%
|
579
|
| Selling, general and administrative |
—
|
107
-14.6%
|
114
-9.3%
|
126
-22.7%
|
162
+59.1%
|
102
|
| Operating income |
—
|
-270
-61.0%
|
-321
-90.9%
|
-168
+89.2%
|
-1,561
-1109.5%
|
-129
|
| Other income (expense) |
—
|
-51
-221.2%
|
15
+192.8%
|
-16
-1397.3%
|
1
+107.0%
|
-17
|
| Pretax income |
—
|
-321
-74.7%
|
-306
-66.5%
|
-184
+88.2%
|
-1,560
-965.4%
|
-146
|
| Income tax |
—
|
2
-24.9%
|
4
+62.8%
|
3
+44.7%
|
2
|
0
|
| Net income |
—
|
-148
-156.1%
|
-136
-135.1%
|
-58
+78.6%
|
-270
-84.5%
|
-146
|
| Basic EPS |
—
|
-45.26
-7319.7%
|
-46.78
-7568.9%
|
-0.61
+90.6%
|
-6.50
|
—
|
| Diluted EPS |
—
|
-45.26
-7084.1%
|
-54.06
-8481.0%
|
-0.63
+90.3%
|
-6.50
|
—
|
| Weighted average shares, basic |
—
|
3
-96.6%
|
3
-96.9%
|
95
+128.2%
|
42
|
—
|
| Weighted average shares, diluted |
—
|
3
-98.9%
|
3
-99.0%
|
295
+608.5%
|
42
|
—
|
| Other measures | ||||||
| Depreciation and amortization |
—
|
86
-0.7%
|
86
-0.7%
|
87
-0.7%
|
87
+5442.2%
|
2
|
| EBITDA |
—
|
-184
-126.7%
|
-235
-188.7%
|
-81
+94.5%
|
-1,474
-1055.9%
|
-127
|
| Margins | ||||||
| Operating margin |
—
|
-18.53%
|
-21.37%
|
-13.26%
|
-148.73%
|
-22.31%
|
| Pretax margin |
—
|
-22.00%
|
-20.39%
|
-14.51%
|
-148.62%
|
-25.30%
|
| Profit margin |
—
|
-10.14%
|
-9.05%
|
-4.56%
|
-25.74%
|
-25.30%
|
| EBITDA margin |
—
|
-12.63%
|
-15.64%
|
-6.42%
|
-140.42%
|
-22.03%
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.
New to this? Read How to Read an Income Statement, With a Real Example.
Company profile
- Industry
- Services-Health Services (SIC 8000)
- Listed as
- PIII (Nasdaq), PIIIW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Chicago, IL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1832511
- Former names
- Foresight Acquisition Corp. (until Dec 3, 2021)
Other Services-Health Services companies
- LifeStance Health Group, Inc. LFST
- Privia Health Group, Inc. PRVA
- GeneDx Holdings Corp. WGS
- Pennant Group, Inc. PNTG
- U S Physical Therapy Inc /NV USPH
- InnovAge Holding Corp. INNV
- Omada Health, Inc. OMDA
- Alps Group Inc ALPS
Source: SEC EDGAR filings. This is company-reported data, not investment advice.